drugset / Trial / NCT00534872

A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population

NCT00534872

Phase 1 Withdrawn GlaxoSmithKline
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the blood levels and the tolerability of SB-649868 in Elderly and Female population

Timeline

Start
2007-10
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject SB-649868 Small molecule 10 mg

Indications